What's new in vascular surgery

Journal of the American College of Surgeons

Volumn 198, Issue 4, 2004, Pages 600-625

  Ricotta, John J ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMFEBUTAMONE; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C5; DNA; DOXYCYCLINE; HEPARIN; NICOTINE; PROTHROMBIN A; TROPONIN;

ABDOMINAL AORTA ANEURYSM; ANGIOGRAPHY; AORTA ANEURYSM; AORTA CLAMPING; AORTOPLASTY; ARTERY BYPASS; BLOOD PUMP; BLOOD VESSEL PROSTHESIS; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY SURGERY; CAROTID ENDARTERECTOMY; CATHETER; CLAUDICATION; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORONARY STENT; CORRELATION ANALYSIS; CUFF; ELECTROCARDIOGRAM; ENDARTERECTOMY; ENDOLEAK; ENDOVASCULAR SURGERY; EXPLANT; EXTRACORPOREAL CIRCULATION; EXTRAVASATION; HEART GRAFT; HEART INFARCTION; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; INTRAVASCULAR ULTRASOUND; LAPAROSCOPIC SURGERY; LIFE EXPECTANCY; MULTIPLE ORGAN FAILURE; NEUROLOGICAL COMPLICATION; NICOTINE REPLACEMENT THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCIATIC NEUROPATHY; SMOKING CESSATION; SPINAL CORD ISCHEMIA; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBECTOMY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASCULAR DISEASE; VASCULAR SURGERY; VENOUS THROMBOEMBOLISM;

AORTIC ANEURYSM; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERY DISEASES; HUMANS; RENAL DIALYSIS; THROMBOEMBOLISM; VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES; VEINS;

EID: 1842609936     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.01.010     Document Type: Conference Paper

References (235)

1. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 347:2002;1916-1923.
2. Rosand J., Altshuler D. Human genome sequence variation and the search for genes. Stroke. 34:2003;2512-2516.
3. Izawa H., Yamada Y., Okada T., et al. Prediction of genetic risk for hypertension. Hypertension. 41:2003;1035-1040.
4. Kibbe M.R., Hassett A.L., McSherry F., et al. Can screening for genetic markers improve peripheral artery bypass patency? J Vasc Surg. 36:2002;1198-1206.
5. Brown M.J., Burton P.R., Horsburgh T., et al. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms a case-control study. J Vasc Surg. 37:2003;999-1005.
6. Nabel E.G. Cardiovascular disease. N Engl J Med. 23:2003;60-72.
7. Ridker P.M., Rifai N., Rose L., et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 347:2002;1557-1565.
8. Ariyo A.A., Thach C., Tracy R. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med. 349:2003;2108-2115.
9. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 348:2003;593-600.
10. Kurvers H.A., van der Graaf Y., Blankensteijn J.D., et al. Screening for asymptomatic internal carotid artery stenosis and aneurysm of the abdominal aorta comparing the yield between patients with manifest atherosclerosis and patients with risk factors for atherosclerosis only. J Vasc Surg. 37:2003;1226-1233.
11. Jacobowitz G.R., Rockman C.B., Gagne P.J., et al. A model for predicting occult carotid artery stenosis screening is justified in a selected population. J Vasc Surg. 38:2003;705-709.
12. Boll A.P., Severens J.L., Verbeek A.L., van der Vliet J.A. Mass screening on abdominal aortic aneurysm in men aged 60 to 65 years in The Netherlands. Impact on life expectancy and cost-effectiveness using a Markov model. Eur J Vasc Endovasc Surg. 26:2003;74-80.
13. Frydman G., Walker P.J., Summers K., et al. The value of screening in siblings of patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 26:2003;396-400.
14. Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin- converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342:2000;145-153.
15. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals a randomised placebo-controlled trial. Lancet. 360:2002;7-22.
16. Cassar K., Coull R., Bachoo P., et al. Management of secondary risk factors in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 26:2003;262-266.
17. Burns P., Lima E., Bradbury A.W. Second best medical therapy. Eur J Vasc Endovasc Surg. 24:2002;400-404.
18. Henke P.K., Blackburn S., Proctor M., et al. Patients with operative peripheral vascular occlusive disease are underprescribed cardioprotective medications effect on graft patency, limb salvage and mortality. JVS. 39:2004;357-365.
19. Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 348:2003;383-393.
20. Cowan J.A. Jr, Dimick J.B., Wainess R.M., et al. Ruptured thoracoabdominal aortic aneurysm treatment in the United States 1988 to 1998. J Vasc Surg. 38:2003;319-322.
21. Dimick J.B., Cowan J.A. Jr, Henke P.K., et al. Hospital volume-related differences in aorto-bifemoral bypass operative mortality in the United States. J Vasc Surg. 37:2003;970-975.
22. Matsen S.L., Perler B.A., Brown P.M. Jr, et al. The distribution of carotid endarterectomy procedures among surgeons and hospitals in New York state is regionalization of specialized vascular care occurring? J Vasc Surg. 36:2002;1146-1153.
23. Brewster D.C., Cronenwett J.L., Hallett J.W., et al. Special communication guidelines for the treatment of abdominal aortic aneurysms. J Vasc Surg. 37:2003;1106-1117.
24. Tambyraja A.L., Stuart W.P., Sala Tenna A., et al. Non-operative management of high-risk patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 26:2003;401-404.
25. Wanhainen A., Bergqvist D., Bjorck M. Measuring the abdominal aorta with ultrasonography and computed tomography-difference and variability. Eur J Vasc Endovasc Surg. 24:2002;428-434.
26. Fillinger M.F., Racusin J., Baker R.K., et al. Anatomic characteristics of ruptured abdominal aortic aneurysms implications for rupture risk and potential for endovascular repair. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL June;Abstract S5:30.
27. Fillinger M.F., Marra S.P., Raghavan M.L., Kennedy F.E. Prediction of rupture risk in abdominal aortic aneurysm during observation wall stress versus diameter. J Vasc Surg. 37:2003;724-732.
28. Papavassiliou V., Anderton M., Loftus I.M., et al. The physiological effects of elevated intra-abdominal pressure following aneurysm repair. Eur J Vasc Endovasc Surg. 26:2003;293-298.
29. Sala F., Hassen-Khodja R., Branchereau P., et al. Outcome of common iliac arteries after aortoaortic graft placement during elective repair of infrarenal abdominal aortic aneurysms. J Vasc Surg. 36:2002;982-987.
30. Ailawadi G., Knipp B.S., Lu G., et al. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vasc Surg. 37:2003;1059-1066.
31. Sho E., Sho M., Kimura H., et al. Hemodynamic forces modulate murine AAA progression. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract LL2:46.
32. Lindholt J.S., Jorgensen B., Klitgaard N.A., Henneberg E.W. Systemic levels of cotinine and elastase, but not pulmonary function, are associated with the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 26:2003;418-422.
33. Eliason J.L., Ailawadi G., Sinha I., et al. Neutrophil depletion inhibits experimental aortic aneurysm formation unrelated to MMP-2 and MMP-9. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract LL1:44.
34. Tambiah J., Powell J.T. Chlamydia pneumoniae antigens facilitate experimental aortic dilatation prevention with azithromycin. J Vasc Surg. 36:2002;1011-1017.
35. Petersen E., Boman J., Wagberg F., Angquist K.A. Presence of Chlamydia pneumoniae in abdominal aortic aneurysms is not associated with increased activity of matrix metalloproteinases. Eur J Vasc Endovasc Surg. 24:2002;365-369.
36. Hoel A.W., Buckley C., Goeddel L.A., Thompson R.W. Doxycycline-mediated suppression of elastase-induced abdominal aortic aneurysms is accompanied by an increase in aortic wall tensile strength. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract LL3:48.
37. Allaire E., Muscatelli-Groux B., Mandet C., et al. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J Vasc Surg. 36:2002;1018-1026.
38. Harkin D.W., Rubin B.B., Romaschin A.D., Lindsay T.F. Complement C5a receptor antagonist attenuates multiple organ dysfunction following ruptured abdominal aortic aneurysm. JVS. 39:2004;196-206.
39. van der Bas J.M., Quax P.H., van den Berg A.C., et al. Ingrowth of aorta vascular cells into basic fibroblast growth factor-impregnated vascular prosthesis material a porcine and human in vitro study on blood vessel prosthesis healing. J Vasc Surg. 36:2002;1237-1247.
40. Cakir O., Erdem K., Oruc A., et al. Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury. Cardiovasc Surg. 11:2003;375-379.
41. Buth J., Taylor P., Harris P.L., et al. Experience accumulated in the combined Eurostar and UK thoracic aortic endograft registries. 2003;. Presented at VEITH Symposium November; New York City, NY, Session XVII.
42. Lamme B., de Jonge I.C., Reekers J.A., et al. Endovascular treatment of thoracic aortic pathology feasibility and mid-term results. Eur J Vasc Endovasc Surg. 25:2003;532-539.
43. Lambrechts D., Casselman F., Schroeyers P., et al. Endovascular treatment of the descending thoracic aorta. Eur J Vasc Endovasc Surg. 26:2003;437-444.
44. Lepore V., Lonn L., Delle M., et al. Endograft therapy for diseases of the descending thoracic aorta results in 43 high-risk patients. J Endovasc Ther. 9:2002;829-837.
45. Bell R.E., Taylor P.R., Aukett M., et al. Results of urgent and emergency thoracic procedures treated by endoluminal repair. Eur J Vasc Endovasc Surg. 25:2003;527-531.
46. Grabenwoger M., Fleck T., Czerny M., et al. Endovascular stent graft placement in patients with acute thoracic aortic syndromes. Eur J Cardiothorac Surg. 23:2003;788-793. discussion 793.
47. Pamler R.S., Kotsis T., Gorich J., et al. Complications after endovascular repair of type B aortic dissection. J Endovasc Ther. 9:2002;822-828.
48. Hansen C., Aziz I., Kim B., et al. Complications of endovascular repair of high-risk and emergent descending thoracic aortic aneurysms and dissections. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract 17:90.
49. Criado F.J., Clark N.S., Barnatan M.F. Stent graft repair in the aortic arch and descending thoracic aorta a 4-year experience. J Vasc Surg. 36:2002;1121-1128.
50. Ellozy S.H., Carroccio A., Minor M., et al. Challenges of endovascular tube graft repair of thoracic aortic aneurysm midterm follow-up and lessons learned. J Vasc Surg. 38:2003;676-683.
51. Marty-Ane C.H., Berthet J.P., Branchereau P., et al. Endovascular repair for acute traumatic rupture of the thoracic aorta. Ann Thorac Surg. 75:2003;1803-1807.
52. Kwon C.C., Gill I.S., Fallon W.F., et al. Delayed operative intervention in the management of traumatic descending thoracic aortic rupture. Ann Thorac Surg. 74:2002;S1888-1891. discussion S1892-1898.
53. McWilliams R.G., Fearn S.J., Harris P.L., et al. Retrograde fenestration of endoluminal grafts from target vessels feasibility, technique, and potential usage. J Endovasc Ther. 10:2003;946-952.
54. Saccani S., Nicolini F., Beghi C., et al. Thoracic aortic stents a combined solution for complex cases. Eur J Vasc Endovasc Surg. 24:2002;423-427.
55. Chuter T.A., Schneider D.B., Reilly L.M., et al. Modular branched stent graft for endovascular repair of aortic arch aneurysm and dissection. J Vasc Surg. 38:2003;859-863.
56. Kieffer E., Chiche L., Baron J.F., et al. Coronary and carotid artery disease in patients with degenerative aneurysm of the descending thoracic or thoracoabdominal aorta prevalence and impact on operative mortality. Ann Vasc Surg. 16:2002;679-684.
57. Miller C.C. 3rd, Porat E.E., Estrera A.L., et al. Analysis of short-term multivariate competing risks data following thoracic and thoracoabdominal aortic repair. Eur J Cardiothorac Surg. 23:2003;1023-1027. discussion 1027.
58. Goueffic Y., Chaillou P., Pillet J.C., et al. Surgical treatment of nonaneurysmal aortic arch lesions in patients with systemic embolization. J Vasc Surg. 36:2002;1186-1193.
59. Klocker J., Oldenburg W.A., Neuhauser B., et al. Natural history of blue toe syndrome in patients with mobile debris in the thoracic aorta as defined by transesophageal echocardiography. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract S8:36.
60. Forbes T.L., DeRose G., Kribs S.W., et al. Cumulative sum failure analysis of the learning curve with endovascular abdominal aortic aneurysm repair. JVS. 39:2004;102-108.
61. Anderson P.L., Arons R.R., Clair D., et al. A statewide experience with endovascular AAA repair-rapid diffusion with excellent early results. JVS. 39:2004;10-19.
62. Criado F.J., Fairman R.M., Becker G.J. Talent LPS AAA stent graft results of a pivotal clinical trial. J Vasc Surg. 37:2003;709-715.
63. Carpenter J.P., Brewster D.C., Kwolek C., et al. Multicenter trial results of the lifepath system for endovascular aortic aneurysm repair (EVAR). JVS. 39:2004;34-43.
64. Parlani G., Verzini F., Zannetti S., et al. Does gender influence outcome of AAA endoluminal repair? Eur J Vasc Endovasc Surg. 26:2003;69-73.
65. Peppelenbosch A.G., Buth J., Harris P.L., et al. Diameter of abdominal aortic aneurysm and outcome of endovascular repair. Does the size matter? A report from the EUROSTAR. JVS. 39:2004;288-297.
66. Ouriel K., Srivastava S.D., Sarac T.P., et al. Disparate outcome after endovascular treatment of small versus large abdominal aortic aneurysm. J Vasc Surg. 37:2003;1206-1212.
67. Greenhalgh R.M., Brown L.C. Update on UK randomized prospective comparison of open and endo AAA repairs in standard and high-risk patients. 2003;. Presented at VEITH Symposium November;New York City, NY, Session XVII.
68. Schermerhorn M.L., Finlayson S.R., Fillinger M.F., et al. Life expectancy after endovascular versus open abdominal aortic aneurysm repair results of a decision analysis model on the basis of data from EUROSTAR. J Vasc Surg. 36:2002;1112-1120.
69. Ingle H., Fishwick G., Thompson M.M., Bell P.R. Endovascular repair of wide neck AAA-preliminary report on feasibility and complications. Eur J Vasc Endovasc Surg. 24:2002;123-127.
70. Cao P., Verzini F., Parlani G., et al. Predictive factors and clinical consequences of proximal aortic neck dilatation in 230 patients undergoing abdominal aorta aneurysm repair with self-expandable stent-grafts. J Vasc Surg. 37:2003;1200-1205.
71. Sternbergh W.C. III, Money S., Greenberg R.K., Chuter T.A. Influence of endograft oversizing on device migration, endoleak and aortic neck dilation results from the Zenith multicenter trial. JVS. 39:2004;20-27.
72. Dillavou E.D., Muluk S., Makaroun M.S. Is neck dilation after endovascular aneurysm repair graft dependent? Results of four US Phase II trials. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June:148.
73. Ouriel K., Clair D.G., Greenberg R.K., et al. Endovascular repair of abdominal aortic aneurysms device-specific outcome. J Vasc Surg. 37:2003;991-998.
74. May J., White G.H., Ly C.N., et al. Endoluminal repair of abdominal aortic aneurysm prevents enlargement of the proximal neck a 9-year life-table and 5-year longitudinal study. J Vasc Surg. 37:2003;86-90.
75. Garret H.E. Jr, Abdullah A.H., Hodgkiss T.D., Burgar S.R. Intravascular ultrasound aids in the performance of endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 37:2003;615-618.
76. Sonesson B., Dias N., Malina M., et al. Intra-aneurysm pressure measurements in successfully excluded abdominal aortic aneurysm after endovascular repair. J Vasc Surg. 37:2003;733-738.
77. Milner R., Verhagen H.J.M., Prinssen M., Blankensteijn J.D. Transcutaneous, non-invasive, intrasac pressure measurement in an animal model of abdominal aortic aneurysm. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract 15:86.
78. Carroccio A., Marin M.L., Hollier L.H. Clinical experience with the Remon device for continuous measurement of AAA intrasac pressures following EVAR. 2003;. Presented at VEITH Symposium, November;New York, NY, Session VI.
79. Faries P.L. Accuracy of cine magnetic resonance angiography in quantifying aneurysm pulsatility associated with endoleak. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract BN2:174.
80. Insko E.K., Kulzer L.M., Fairman R.M., et al. MR imaging for the detection of endoleaks in recipients of abdominal aortic stent-grafts with low magnetic susceptibility. Acad Radiol. 10:2003;509-513.
81. Lookstein R.A., Goldman J.P., Pukin L., Marin M.L. Time resolved MRA as a non-invasive method to characterize endoleaks comparison with conventional angiography. JVS. 39:2004;27-33.
82. Meier G.H., Sprouse L.R., Lesar C., et al. How does endoleak influence aneurysm sac morphology after endovascular aortic repair? American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June:150.
83. Stavropoulos S.W., Baum R.A., Fairman R.M., et al. Can CTA be used to classify endoleaks? American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL June;Abstract A3:100.
84. Parra J.R., Ayerdi J., McLafferty R., et al. Conformational changes associated with proximal seal zone failure in abdominal aortic endografts. J Vasc Surg. 37:2003;106-111.
85. Vallabhaneni S.R., Gilling-Smith G.L., How T.V., et al. Aortic side branch perfusion alone does not account for high intra-sac pressure after endovascular repair (EVAR) in the absence of graft-related endoleak. Eur J Vasc Endovasc Surg. 25:2003;354-359.
86. Forester N.D., Parry D., Kessel D., et al. Ischaemic sciatic neuropathy an important complication of embolisation of a type II endoleak. Eur J Vasc Endovasc Surg. 24:2002;462-463.
87. Sugano N., Inoue Y., Iwai T. Evaluation of buttock claudication with hypogastric artery stump pressure measurement and near infrared spectroscopy after abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 26:2003;45-51.
88. Lee W.A., Berceli S.A., Huber T.S., Seeger J.M. A technique for combined hypogastric artery bypass and endovascular repair of complex aortoiliac aneurysms. J Vasc Surg. 35:2002;1289-1291.
89. Wyers M.C., Schermerhorn M.L., Fillinger M.F., et al. Internal iliac occlusion without coil embolization during endovascular abdominal aortic aneurysm repair. J Vasc Surg. 36:2002;1138-1145.
90. Steinmetz E., Rubin B.G., Sanchez L.A., et al. Type II endoleaks after endovascular AAA repair is a conservative approach safe and cost effective. JVS. 39:2004;306-313.
91. Faries P.L., Cadot H., Agarwal G., et al. Management of endoleak after endovascular aneurysm repair cuffs, coils, and conversion. J Vasc Surg. 37:2003;1155-1161.
92. Becquemin J.P., Kelley L., Zubilewicz T., et al. Outcomes of secondary interventions following endovascular repair of AAA. JVS. 39:2004;298-305.
93. Maldonado T.S., Rosen R.J., Rockman C.B., et al. Initial successful management of type I endoleak after endovascular aortic aneurysm repair with n-butyl cyanoacrylate adhesive. J Vasc Surg. 38:2003;664-670.
94. Kolvenbach R., Pinter L., Raghunandan M., et al. Laparoscopic remodeling of abdominal aortic aneurysms after endovascular exclusion a technical description. J Vasc Surg. 36:2002;1267-1270.
95. Jacobs T.S., Won J., Gravereaux E.C., et al. Mechanical failure of prosthetic human implants a 10-year experience with aortic stent graft devices. J Vasc Surg. 37:2003;16-26.
96. Parosi J.C., Mura R.L., Ferreira L.M. Safety maneuvers to prevent embolism complicating endovascular aortic repair. JVS. 36:2002;1076-1078.
97. Lau L.L., Hakaim A.G., Oldenburg W.A., et al. Effect of suprarenal versus infrarenal aortic endograft fixation on renal function and renal artery patency a comparative study with intermediate follow-up. J Vasc Surg. 37:2003;1162-1168.
98. Bove P.G., Long G.W., Shanley C.J., et al. Transrenal fixation of endovascular stent-grafts for infrarenal aortic aneurysm repair mid-term results. J Vasc Surg. 37:2003;938-942.
99. Cayne N.S., Rhee S.J., Veith F.J., et al. Does transrenal fixation of aortic endografts impair renal function? J Vasc Surg. 38:2003;639-644.
100. Surowiec S.M., Davies M.G., Fegley A.J., et al. The relationship of proximal fixation to post-opertive renal dysfunction in patients with normal serum creatinine. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June:154.
101. Van Herzeele I., Vermassen F., Durieux C., et al. Endovascular repair of aortic rupture. Eur J Vasc Endovasc Surg. 26:2003;311-316.
102. Peppelenbosch N., Yilmaz N., van Marrewijk C., et al. Emergency treatment of acute symptomatic or ruptured abdominal aortic aneurysm. Outcome of a prospective intent-to-treat by EVAR protocol. Eur J Vasc Endovasc Surg. 26:2003;303-310.
103. Magnan P.E., Albertini J.N., Bartoli J.M., et al. Endovascular treatment of anastomotic false aneurysms of the abdominal aorta. Ann Vasc Surg. 17:2003;365-374.
104. Hickey N.C., Caldwell S.P. Aortic surgery through a transverse mini-laparotomy. Eur J Vasc Endovasc Surg. 25:2003;369-370.
105. Alimi Y.S., Di Molfetta L., Hartung O., et al. Laparoscopy-assisted abdominal aortic aneurysm endoaneurysmorraphy early and mid-term results. J Vasc Surg. 37:2003;744-749.
106. Wisselink W., Cuesta M.A., Gracia C., Rauwerda J.A. Robot-assisted laparoscopic aortobifemoral bypass for aortoiliac occlusive disease a report of two cases. J Vasc Surg. 36:2002;1079-1082.
107. Larson R.A., Solomon J., Carpenter J.P. Stent graft repair of visceral artery aneurysms. J Vasc Surg. 36:2002;1260-1263.
108. Tielliu I.F., Verhoeven E.L., Prins T.R., et al. Treatment of popliteal artery aneurysms with the Hemobahn stent-graft. J Endovasc Ther. 10:2003;111-116.
109. Mahmood A., Salaman R., Sintler M., et al. Surgery of popliteal artery aneurysms a 12-year experience. J Vasc Surg. 37:2003;586-593.
110. Goncalves I., Moses J., Pedro L.M., et al. Echolucency of carotid plaques correlates with plaque cellularity. Eur J Vasc Endovasc Surg. 26:2003;32-38.
111. Russell D.A., Wijeyaratne M., Mavor A.I.D., et al. Changes in carotid plaque echomorphology after a neurological event. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract 14:84.
112. Brown O.W., Bendick P.J., Shanley C.J., et al. Reliability of extracranial carotid artery duplex ultrasound examinations the value of vascular laboratory accreditation. JVS. 39:2004;366-371.
113. Raman K.G., Layne S., Makaroun M.S., et al. Contralateral disease progression is common after carotid endarterectomy. JVS. 39:2004;52-59.
114. MacKenzie R., Nimmo F., Bachoo P., et al. The relationship between socio-economic status, geography, symptomatic carotid territory disease and carotid endarterectomy. Eur J Vasc Endovasc Surg. 26:2003;145-149.
115. Eckstein H.H., Ringleb P., Dorfler A., et al. The Carotid Surgery for Ischemic Stroke trial a prospective observational study on carotid endarterectomy in the early period after ischemic stroke. J Vasc Surg. 36:2002;997-1004.
116. Illig K.A., Zhang R., Tanski W., et al. Is the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified? J Vasc Surg. 37:2003;575-581.
117. Gasparis A.P., Ricotta L., Cuadra S.A., et al. High-risk carotid endarterectomy fact or fiction. J Vasc Surg. 37:2003;40-46.
118. Reed A.B., Gaccione P., Belkin M., et al. Preoperative risk factors for carotid endarterectomy defining the patient at high risk. J Vasc Surg. 37:2003;1191-1199.
119. Ohki T., Veith F.J., Grenell S., et al. Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting. J Vasc Surg. 36:2002;1175-1185.
120. Cremonesi A., Manetti R., Setacci F., et al. Protected carotid stenting clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke. 34:2003;1936-1941.
121. Kastrup A., Groschel K., Krapf H., et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices a systematic review of the literature. Stroke. 34:2003;813-819.
122. Ramaiah V.G., Gowda R., Rodriguez-Lopez J.A., et al. Initial experience with carotid angioplasty and stenting with neuroprotection devices. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract BN5:180.
123. Yadav J.S. Stenting and angioplasty with protection in patients at high risk for endarterectomy The SAPPHIRE study. Circulation. 106:2003;2986.
124. Ouriel K., Yadav J.S., Wholey M., et al. The SAPPHIRE randomized trial of carotid stenting versus endarterectomy a subgroup analysis. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract 16:88.
125. Leisch F., Kerschner K., Hofmann R., et al. Carotid sinus reactions during carotid artery stenting predictors, incidence, and influence on clinical outcome. Catheter Cardiovasc Interv. 58:2003;516-523.
126. Wholey M.H., Eles G., Toursakissian B., et al. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther. 10:2003;33-41.
127. Willfort-Ehringer A., Ahmadi R., Gruber D., et al. Effect of carotid artery stenting on the external carotid artery. J Vasc Surg. 38:2003;1039-1044.
128. Schluter M., Tubler T., Steffens J.C., et al. Focal ischemia of the brain after neuroprotected carotid artery stenting. J Am Coll Cardiol. 42:2003;1007-1013.
129. Bicknell C.D., Cowling M.G., Clark M.W., et al. Carotid angioplasty in a pulsatile flow model factors affecting embolic potential. Eur J Vasc Endovasc Surg. 26:2003;22-31.
130. Tan K.T., Cleveland T.J., Berczi V., et al. Timing and frequency of complications after carotid artery stenting what is the optimal period of observation? J Vasc Surg. 38:2003;236-243.
131. Khan M.A., Liu M.W., Chio F.L., et al. Predictors of restenosis after successful carotid artery stenting. Am J Cardiol. 92:2003;895-897.
132. Christiaans M.H., Ernst J.M., Suttorp M.J., et al. Restenosis after carotid angioplasty and stenting a follow-up study with duplex ultrasonography. Eur J Vasc Endovasc Surg. 26:2003;141-144.
133. Lal B.K., Hobson R.W.I., Goldstein J., Chakhtura E. Carotid artery stenting a need to revise ultrasound velocity criteria for stenosis? JVS. 39:2004;58-66.
134. Bendok B.R., Roubin G.S., Katzen B.T., et al. Cutting balloon to treat carotid in-stent stenosis technical note. J Invasive Cardiol. 15:2003;227-232.
135. de Borst G.J., Ackerstaff R.G., Mauser H.W., Moll F.L. Operative management of carotid artery in-stent restenosis first experiences and duplex follow-up. Eur J Vasc Endovasc Surg. 26:2003;137-140.
136. Bowser A.N., Bandyk D.F., Evans A., et al. Outcome of carotid stent-assisted angioplasty versus open surgical repair of recurrent carotid stenosis. J Vasc Surg. 38:2003;432-438.
137. Grego F., Frigatti P., Lepidi S., et al. Synchronous carotid endarterectomy and retrograde endovascular treatment of brachiocephalic or common carotid artery stenosis. Eur J Vasc Endovasc Surg. 26:2003;392-395.
138. Hobson R.W. 2nd, Lal B.K., Chakhtoura E., et al. Carotid artery stenting analysis of data for 105 patients at high risk. J Vasc Surg. 37:2003;1234-1239.
139. Warren J.A., Jordan W.D. Jr, Heudebert G.R., et al. Determining patient preference for treatment of extracranial carotid artery stenosis carotid angioplasty and stenting versus carotid endarterectomy. Ann Vasc Surg. 17:2003;15-21.
140. Hobbs S.D., Bradbury A.W. Smoking cessation strategies in patients with peripheral arterial disease an evidence-based approach. Eur J Vasc Endovasc Surg. 26:2003;341-347.
141. Harrison E.M., Holdsworth R.J. How many claudicants should be prescribed statins? Eur J Vasc Endovasc Surg. 25:2003;367-368.
142. Hiatt W.R. Pharmacologic therapy for peripheral arterial disease and claudication. J Vasc Surg. 36:2002;1283-1291.
143. Rajagopalan S., Mohler E.R. 3rd, Lederman R.J., et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 108:2003;1933-1938.
144. Conners M.S., Money S.R. Can claudication be improved with medication? Semin Vasc Surg. 15:2002;237-244.
145. Degischer S., Labs K.H., Hochstrasser J., et al. Physical training for intermittent claudication a comparison of structured rehabilitation versus home-based training. Vasc Med. 7:2002;109-115.
146. Fowler B., Jamrozik K., Norman P., et al. Improving maximum walking distance in early peripheral arterial disease randomised controlled trial. Aust J Physiother. 48:2002;269-275.
147. Amann W., Berg P., Gersbach P., et al. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg. 26:2003;280-286.
148. van Bemmelen P., Char D., Giron F., Ricotta J.J. Angiographic improvement after rapid intermittent compression treatment [ArtAssist] for small vessel obstruction. Ann Vasc Surg. 17:2003;224-228.
149. Comerota A.J., Throm R.C., Miller K.A., et al. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia preliminary results of a phase I trial. J Vasc Surg. 35:2002;930-936.
150. Gabeler E.E., van Hillegersberg R., Statius van Eps R.G., et al. Endovascular photodynamic therapy with aminolaevulinic acid prevents balloon induced intimal hyperplasia and constrictive remodelling. Eur J Vasc Endovasc Surg. 24:2002;322-331.
151. Hansrani M., Overbeck K., Smout J., Stansby G. Intravascular brachytherapy a systematic review of its role in reducing restenosis after endovascular treatment in peripheral arterial disease. Eur J Vasc Endovasc Surg. 24:2002;377-382.
152. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease six-month results. Circulation. 106:2002;1505-1509.
153. Edrees W.K., Lau L.L., Young I., et al. The effect of lower limb ischaemia-reperfusion on intestinal permeability and the systemic inflammatory response. Eur J Vasc Endovasc Surg. 25:2003;330-335.
154. Silvestro A., Scopacasa F., Oliva G., et al. Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis. 165:2002;277-283.
155. Tiwari A., Cheng K.S., Salacinski H., et al. Improving the patency of vascular bypass grafts the role of suture materials and surgical techniques on reducing anastomotic compliance mismatch. Eur J Vasc Endovasc Surg. 25:2003;287-295.
156. Begovac P.C., Thomson R.C., Fisher J.L., et al. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization. Eur J Vasc Endovasc Surg. 25:2003;432-432.
157. Mann M.J., Conte M.S. Transcription factor decoys for the prevention of vein graft failure. Am J Cardiovasc Drugs. 2003;79-85.
158. Lee T., Seo J.W., Sumpio B.E., Kim S.J. Immunobiologic analysis of arterial tissue in Buerger's disease. Eur J Vasc Endovasc Surg. 25:2003;451-457.
159. Lindholt J.S. Radiocontrast induced nephropathy. Eur J Vasc Endovasc Surg. 25:2003;296-304.
160. Sam A.D. 2nd, Morasch M.D., Collins J., et al. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg. 38:2003;313-318.
161. Hofmann W.J., Forstner R., Kofler B., et al. Pedal artery imaging - a comparison of selective digital subtraction angiography, contrast enhanced magnetic resonance angiography and duplex ultrasound. Eur J Vasc Endovasc Surg. 24:2002;287-292.
162. Soule B., Hingorani A., Ascher E., et al. Comparison of magnetic resonance angiography (MRA) and duplex ultrasound arterial mapping (DUAM) prior to infrainguinal arterial reconstruction. Eur J Vasc Endovasc Surg. 25:2003;139-146.
163. Eiberg J.P., Madycki G., Hansen M.A., et al. Ultrasound imaging of infrainguinal arterial disease has a high interobserver agreement. Eur J Vasc Endovasc Surg. 24:2002;293-299.
164. Eiberg J.P., Hansen M.A., Jensen F., et al. Ultrasound contrast-agent improves imaging of lower limb occlusive disease. Eur J Vasc Endovasc Surg. 25:2003;23-28.
165. Back M.R., Bowser A.N., Schmacht D.C., et al. Duplex selection facilitates single point-of-service endovascular and surgical management of aortoiliac occlusive disease. Ann Vasc Surg. 16:2002;566-574.
166. Queral L.A., Lucas P.R., Badder E.M. Lower extremity revascularization based on intraoperative arteriography. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract A17:132.
167. Richards T., Pittathankal A.A., Magee T.R., Galland R.B. The current role of intra-arterial thrombolysis. Eur J Vasc Endovasc Surg. 26:2003;166-169.
168. Sugimoto K., Hofmann L.V., Razavi M.K., et al. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. J Vasc Surg. 37:2003;512-517.
169. Mumme A., Heinen W., Geier B., et al. Regional hyperthermic fibrinolytic perfusion after unsuccessful venous thrombectomy of extensive deep venous thrombosis. J Vasc Surg. 36:2002;1219-1224.
170. Sarac T.P., Hilleman D., Arko F., et al. Safety, efficacy and cost of a single combined mechanical and pharmacologic thrombectomy catheter for acute and chronic arterial occlussion. AAVS Plenary Session. 2003;. June 10:158.
171. Reed A.B., Conte M.S., Donaldson M.C., et al. The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J Vasc Surg. 37:2003;1219-1225.
172. Feugier P., Toursarkissian B., Chevalier J-M., Favre J-P. Endovascular treatment of isolated atherosclerotic stenosis of the infrarenal abdominal aorta long-term outcome. Ann Vasc Surg. 2003;375-385.
173. Greiner A., Dessl A., Klein-Weigel P., et al. Kissing stents for treatment of complex aortoiliac disease. Eur J Vasc Endovasc Surg. 26:2003;161-165.
174. Ali A.T., Modrall J.G., Lopez J., et al. Emerging role of endovascular grafts in complex aortoiliac occlusive disease. J Vasc Surg. 38:2003;486-491.
175. Klinkert P., Schepers A., Burger D.H., et al. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting five-year results of a randomized controlled trial. J Vasc Surg. 37:2003;149-155.
176. Roddy S.P., Darling C., Mehta M., et al. Infrainguinal reconstruction to the above knee popliteal artery using prosthetic. Is the vein really saved? AAVS Plenary Session. 2003;. June 10;Abstract 11:78.
177. Eskelinen E., Luther M., Eskelinen A., Lepantalo M. Infrapopliteal bypass reduces amputation incidence in elderly patients a population-based study. Eur J Vasc Endovasc Surg. 26:2003;65-68.
178. Goshima K.R., Mills J.L., Hughes J.D. A new look at outcomes following infrainguinal bypass surgery have we underestimated the expenditure of effort required to attain limb salvage. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract A14:126.
179. Sheahan M.G., Hamden A.D., Deautsch E.R., et al. A decade of infrainguinal bypass procedures predicting the natural course of lower extremity vascular disease. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract BR1:162.
180. Ramdev P., Rayan S.S., Sheahan M., et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg. 36:2002;969-974.
181. Sheahan M., Aulivola B., Pomposelli F.B. Jr, et al. Amputation-free survival after lower extremity revascularization the adverse impact of even moderate renal dysfunction. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract:BN4:178.
182. Rzucidlo E.M., Walsh D.B., Powell R.J., et al. Prediction of early graft failure with intraoperative completion duplex ultrasound scan. J Vasc Surg. 36:2002;975-981.
183. Ferris B.L., Mills J.L. Sr, Hughes J.D., et al. Is early postoperative duplex scan surveillance of leg bypass grafts clinically important? J Vasc Surg. 37:2003;495-500.
184. Lam E.Y., Taylor L.M., Yeager R.A., et al. Risk factors for autogenous infrainguinal bypass occlusion in patients with prosthetic inflow grafts. JVS. 39:2004;336-342.
185. Mahmood A., Hardy R., Garnham A., et al. Microtibial embolectomy. Eur J Vasc Endovasc Surg. 25:2003;35-39.
186. Smeets L., Ho G.H., Hagenaars T., et al. Remote endarterectomy first choice in surgical treatment of long segmental SFA occlusive disease? Eur J Vasc Endovasc Surg. 25:2003;583-589.
187. Jamsen T.S., Manninen H.I., Tulla H.E., et al. Infrainguinal revascularization because of claudication total long-term outcome of endovascular and surgical treatment. J Vasc Surg. 37:2003;808-815.
188. Nasr M.K., Taylor P.J., Horrocks M. Vascular training in the U.K. femorodistal bypass, an index procedure? Eur J Vasc Endovasc Surg. 25:2003;135-138.
189. Costanza M.J., Queral L.A., Lilly M.P., Flinn W.R. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions. JVS. 39:2004;343-350.
190. Vogel T.R., Shindelman L.E., Nackman G.B., Graham A.M. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg. 38:2003;1178-1184.
191. Becquemin J.P., Favre J.P., Marzelle J., et al. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty a multicenter prospective randomized study. J Vasc Surg. 37:2003;487-494.
192. Pozzi Mucelli F., Fisicaro M., Calderan L., et al. Percutaneous revascularization of femoropopliteal artery disease PTA and PTA plus stent. Results after six years' follow-up. Radiol Med (Torino). 105:2003;339-349.
193. Saxon R.R., Coffman J.M., Gooding J.M., et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 14:2003;303-311.
194. Tisi P.V., Mirnezami A., Baker S., et al. Role of subintimal angioplasty in the treatment of chronic lower limb ischaemia. Eur J Vasc Endovasc Surg. 24:2002;417-422.
195. Laxdal E., Jenssen G.L., Pedersen G., Aune S. Subintimal angioplasty as a treatment of femoropopliteal artery occlusions. Eur J Vasc Endovasc Surg. 25:2003;578-582.
196. Lipsitz E.C., Ohki T., Veith F.J., et al. Fate of collateral vessels following subintimal angioplasty. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract BR4:168.
197. Fowkes F.J., Price J.F., Fowkes F.G. Incidence of diagnosed deep vein thrombosis in the general population systematic review. Eur J Vasc Endovasc Surg. 25:2003;1-5.
198. Buller H.R., Davidson B.L., Decousus H., et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 349:2003;1695-1702.
199. Myers D.D. Jr, Henke P.K., Wrobleski S.K., et al. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. J Vasc Surg. 36:2002;928-938.
200. Myers D.D. Jr, Hawley A.E., Farris D.M., et al. Cellular IL-10 is more effective than viral iL-10 in decreasing venous thrombosis. J Surg Res. 112:2003;168-174.
201. Padberg F.T., Johnston M.V., Sisto S.A. Structured exercise improves calf muscle pump function in patients with severe chronic venous insufficiency (CVI) a randomized trial. JVS. 39:2004;79-87.
202. Zamboni P., Cisno C., Marchetti F., et al. Minimally invasive surgical management of primary venous ulcers vs. compression treatment a randomized clinical trial. Eur J Vasc Endovasc Surg. 25:2003;313-318.
203. Bengisun U., Murat Tagil S., Elhan A. Accessibility of calf perforating veins from the superficial posterior compartment an anatomic dissection study. Eur J Vasc Endovasc Surg. 25:2003;552-555.
204. Wittens C.H.A., van Gent B. Jr, Hop W.C.J., Sybrandy J.E.M. The Dutch subfascial endoscopic perforating vein surgery (SEPS) trial a randomised multicenter trial comparing ambulatory compression therapy versus surgery in patients with venous lug ulcers. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract 18:92.
205. Iafrati M.D., Pare G.J., O'Donnell T.F., Estes J. Is the nihilistic approach to surgical reduction of superficial and perforator vein incompetence for venous ulcer justified? J Vasc Surg. 36:2002;1167-1174.
206. Jeanneret C., Fischer R., Chandler J.G., et al. Great saphenous vein stripping with liberal use of subfascial endoscopic perforator vein surgery (SEPS). Ann Vasc Surg. 2003;. Oct 2 (Epub ahead of print).
207. Adam D.J., Bello M., Hartshorne T., London N.J. Role of superficial venous surgery in patients with combined superficial and segmental deep venous reflux. Eur J Vasc Endovasc Surg. 25:2003;469-472.
208. Mackenzie R.K., Lee A.J., Paisley A., et al. Patient, operative, and surgeon factors that influence the effect of superficial venous surgery on disease-specific quality of life. J Vasc Surg. 36:2002;896-902.
209. Lurie F., Creton D., Eklof B., et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg. 38:2003;207-214.
210. Chang C.J., Chua J.J. Endogenous laser photocoagulation for varicose veins. Lasers Surg Med. 2003;257-262.
211. Scavee V., Lesceu O., Theys S., et al. Hook phlebectomy versus transilluminated powered phlebectomy for varicose vein surgery early results. Eur J Vasc Endovasc Surg. 25:2003;473-475.
212. Madhavan P., Aremu M., Butcher W., et al. Prospective randomised controlled trial conventional versus powered phlebectomy. JVS. 39:2004;88-94.
213. Scultetus A.H. Microthrombectomy reduces post-schlerotherapy pigmentation. A multi-center, randomized trial. American Association of Vascular Surgeons Annual Meeting. 2003;. Chicago, IL, June;Abstract BN3:176.
214. Teebken O.E., Puschmann C., Aper T., et al. Tissue-engineered bioprosthetic venous valve a long-term study in sheep. Eur J Vasc Endovasc Surg. 25:2003;305-312.
215. Neglen P., Raju S. Venous reflux repair with cryopreserved vein valves. J Vasc Surg. 37:2003;552-557.
216. Salles-Cunha S.X., Shuman S., Beebe H.G. Planning endovascular vein valve implantation significance of vein size variability. J Vasc Surg. 37:2003;984-990.
217. Raju S., McAllister S., Neglen P. Recanalization of totally occluded iliac and adjacent venous segments. J Vasc Surg. 36:2002;903-911.
218. Scultetus A.H., Villavicencio J.L., Gillespie D.L., et al. The pelvic venous syndromes analysis of our experience with 57 patients. J Vasc Surg. 36:2002;881-888.
219. Lee B.B., Do Y.S., Byun H.S., et al. Advanced management of venous malformation with ethanol sclerotherapy mid-term results. J Vasc Surg. 37:2003;533-538.
220. Rockman C.B., Rosen R.J., Jacobowitz G.R., et al. Transcatheter embolization of extremity vascular malformations the long-term success of multiple interventions. Ann Vasc Surg. 17:2003;417-423.
221. Fisher C.M., Neale M.L. Outcome of surgery for vascular access in patients commencing haemodialysis. Eur J Vasc Endovasc Surg. 25:2003;342-349.
222. Gormus N., Ozergin U., Durgut K., et al. Comparison of autologous basilic vein transpositions between forearm and upper arm regions. Ann Vasc Surg. 2003;. Oct 2 (E.pub ahead of print).
223. Rosas S.E., Joffe M., Burns J.E., et al. Determinants of successful synthetic hemodialysis vascular access graft placement. J Vasc Surg. 37:2003;1036-1042.
224. Dammers R., Planken R.N., Pouls K.P., et al. Evaluation of 4-mm to 7-mm versus 6-mm prosthetic brachial-antecubital forearm loop access for hemodialysis results of a randomized multicenter clinical trial. J Vasc Surg. 37:2003;143-148.
225. Heise M., Schmidt S., Kruger U., et al. Local haemodynamics and shear stress in cuffed and straight PTFE-venous anastomoses an in-vitro comparison using particle image velocimetry. Eur J Vasc Endovasc Surg. 26:2003;367-373.
226. Hakaim A.G., Nalbandian M.N., Heller J.K., et al. Improved patency of prosthetic arteriovenous grafts with an acute anastomotic angle and flow diffuser. J Vasc Surg. 37:2003;1032-1035.
227. Kiyama H., Imazeki T., Kurihara S., Yoneshima H. Long-term follow-up of polyurethane vascular grafts for hemoaccess bridge fistulas. Ann Vasc Surg. 2003;. Oct 2 (Epub ahead of print).
228. Kovalic A.J., Beattie D.K., Davies A.H. Outcome of ProCol, a bovine mesenteric vein graft, in infrainguinal reconstruction. Eur J Vasc Endovasc Surg. 24:2002;533-534.
229. Green L.D., Lee D.S., Kucey D.S. A metaanalysis comparing surgical thrombectomy, mechanical thrombectomy, and pharmacomechanical thrombolysis for thrombosed dialysis grafts. J Vasc Surg. 36:2002;939-945.
230. Lin P.H., Johnson C.K., Pullium J.K., et al. Transluminal stent graft repair with Wallgraft endoprosthesis in a porcine arteriovenous graft pseudoaneurysm model. J Vasc Surg. 37:2003;175-181.
231. Ryan J.M., Dumbleton S.A., Doherty J., Smith T.P. Technical innovation. Using a covered stent (wallgraft) to treat pseudoaneurysms of dialysis grafts and fistulas. AJR Am J Roentgenol. 180:2003;1067-1071.
232. Ryan S., Calligaro K.D., Scharff J., Dougherty M.J. Management of infected prosthetic dialysis arteriovenous grafts. JVS. 39:2004;73-78.
233. Dammers R., de Haan M.W., Planken N.R., et al. Central vein obstruction in hemodialysis patients results of radiological and surgical intervention. Eur J Vasc Endovasc Surg. 26:2003;317-321.
234. Schwab S.J., Weiss M.A., Rushton F., et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int. 62:2002;1026-1033.
235. Rayan S.S., Terramani T.T., Weiss V.J., Chaikof E.L. The LifeSite Hemodialysis Access System in patients with limited access. J Vasc Surg. 38:2003;714-718.